Ortho Clinical Diagnostics Hold (OCDX) Company Profile
Updated Jul 15, 2022
U.S. Stock Screener:
It appears that the Ortho Clinical Diagnostics Hold (OCDX) stock is no longer trading actively as of date of writing. It may be because the stock trading may have been discontinued by the issuing organization, or may have been suspended from active trading owing to a variety of reasons, or it may be an error in FKnol.com records (please let us know). The following data about this stock is available as of writing in FKnol.com records, and may be obsolete. Ortho Clinical Diagnostics Hold has the following business profile:
Business Profile of Ortho Clinical Diagnostics Hold (OCDX)
Market and Trading Information for Ortho Clinical Diagnostics Hold
The following details were available for trading and market data about the stock of Ortho Clinical Diagnostics Hold as of writing:
Trading Details of Ortho Clinical Diagnostics Hold (OCDX)
Current Share Price:
$17.63
Previous Year's Closing Price:
$21.22
Percentage Price Change (YTD):
-16.92%
Market Cap:
$4.19 billion
52-week Price Range:
$16.04 - $22.99
Dividend Per Share:
$0
EPS (TTM):
0
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
17.46
Company Profile and Business Description for Ortho Clinical Diagnostics Hold
Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay ins...to see full details, pleaseLogin / Register to view.
U.S. Stock Screener:
Peer / Competitor Companies of Diagnostics & Research Sector
Along with Ortho Clinical Diagnostics Holdings plc, the following other peer (competitor) companies also exist within the same Diagnostics & Research - Healthcare sector whose company profile and dividend history is as follows:
▶ 23andMe Holding Co. (ME): 23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics.....See Detailed Company Profile, Dividend History
▶ Akumin Inc. (AKU): Akumin Inc. provides outpatient diagnostic imaging services in the United States. Its centers offer physicians with imaging capabilities to facilitate the....See Detailed Company Profile, Dividend History
▶ Aspira Womens Health Inc. (AWH): Aspira Womens Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help....See Detailed Company Profile, Dividend History
▶ bioAffinity Technologies, Inc. (BIAF): bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company....See Detailed Company Profile, Dividend History
▶ Biodesix, Inc. (BDSX): Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung....See Detailed Company Profile, Dividend History
▶ Brainsway (BWAY): Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-tr....See Detailed Company Profile, Dividend History
▶ Burning Rock Biotech (BNR): Burning Rock Biotech develops solutions for precision medicine in oncology and early cancer detection in the People's Republic of China. The company provides....See Detailed Company Profile, Dividend History
▶ Castle Biosciences (CSTL): Castle Biosciences, Inc., a commercial-stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify stage I and II patients at high risk of metastasis based on biological information from 31 genes within their tumor tissue. The company also offers DecisionDx-UM test, ....See Detailed Company Profile, Dividend History
▶ Centogene NV (CNTG): Centogene B.V. operates as a commercial-stage rare disease company worldwide. It focuses on transforming clinical and genetic data into medical solutions for patients, physicians, and pharmaceutical companies. The company develops rare disease platform, a data repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditar....See Detailed Company Profile, Dividend History
▶ DermTech, Inc. (DMTK): DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases,....See Detailed Company Profile, Dividend History
▶ Exagen (XGN): Exagen Inc. operates as a commercial-stage diagnostics company, develops and markets products for the diagnosis, prognosis, and monitoring of patients affected by autoimmune rheumatic diseases (ARDs). Its lead product includes Avise SLE+CT, a proprietary diagnostic test that provides an enhanced solution for patients with a range of ARDs, such as systemic lupus erythematosus (SLE), rheumatoid arthritis....See Detailed Company Profile, Dividend History
▶ Genetron Holdings Limited (GTH): Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data....See Detailed Company Profile, Dividend History
▶ Inotiv, Inc. (NOTV): Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical....See Detailed Company Profile, Dividend History
▶ iSpecimen Inc. (ISPC): iSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with....See Detailed Company Profile, Dividend History
▶ LumiraDx Limited (LMDX): LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic....See Detailed Company Profile, Dividend History
▶ Mainz Biomed B.V. (MYNZ): Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human....See Detailed Company Profile, Dividend History
▶ MaxCyte, Inc. (MXCT): MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally. Its products include MaxCyte ATx, an....See Detailed Company Profile, Dividend History
▶ MDxHealth SA (MDXH): MDxHealth SA operates as a molecular diagnostics company in Belgium, the Netherlands, Spain, Poland, Italy, the United States, rest of European Union, and....See Detailed Company Profile, Dividend History
▶ Olink Holding AB (publ) (OLK): Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused....See Detailed Company Profile, Dividend History
▶ Prenetics Global Limited (PRE): Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer....See Detailed Company Profile, Dividend History